Skip to main content
. 2022 May 19;12:794170. doi: 10.3389/fcimb.2022.794170

Figure 5.

Figure 5

Functional profiling performed with PICRUSt2. LEfSe analysis of differential functional abundance based on the KEGG pathway map. (A) TPOAb-positive vs. TPOAb-negative women with SCH and no LT4; (B) TPOAb-positive vs. TPOAb-negative women with SCH and low-dose LT4; (C) TPOAb-positive vs. TPOAb-negative women with SCH and high-dose LT4. LDA value distribution histogram: the red and green bars represented metabolic functions with higher abundance. A1, TPOAb-positive women with SCH and no LT4; A2, TPOAb-positive women with SCH and low-dose LT4; A3, TPOAb-positive women with SCH and high-dose LT4; B1, TPOAb-negative women with SCH and no LT4; B2, TPOAb-negative women with SCH and low-dose LT4; B3, TPOAb-negative women with SCH and high-dose LT4.